1. Home
  2. AERT vs INTS Comparison

AERT vs INTS Comparison

Compare AERT & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AERT
  • INTS
  • Stock Information
  • Founded
  • AERT 2012
  • INTS 2012
  • Country
  • AERT Singapore
  • INTS United States
  • Employees
  • AERT N/A
  • INTS N/A
  • Industry
  • AERT Professional Services
  • INTS Biotechnology: Pharmaceutical Preparations
  • Sector
  • AERT Consumer Discretionary
  • INTS Health Care
  • Exchange
  • AERT Nasdaq
  • INTS Nasdaq
  • Market Cap
  • AERT 33.5M
  • INTS 33.4M
  • IPO Year
  • AERT N/A
  • INTS 2023
  • Fundamental
  • Price
  • AERT $0.61
  • INTS $2.37
  • Analyst Decision
  • AERT
  • INTS Strong Buy
  • Analyst Count
  • AERT 0
  • INTS 3
  • Target Price
  • AERT N/A
  • INTS $8.50
  • AVG Volume (30 Days)
  • AERT 70.8K
  • INTS 40.1K
  • Earning Date
  • AERT 02-19-2025
  • INTS 03-13-2025
  • Dividend Yield
  • AERT N/A
  • INTS N/A
  • EPS Growth
  • AERT N/A
  • INTS N/A
  • EPS
  • AERT N/A
  • INTS N/A
  • Revenue
  • AERT $72,141,000.00
  • INTS N/A
  • Revenue This Year
  • AERT N/A
  • INTS N/A
  • Revenue Next Year
  • AERT N/A
  • INTS N/A
  • P/E Ratio
  • AERT N/A
  • INTS N/A
  • Revenue Growth
  • AERT 16.98
  • INTS N/A
  • 52 Week Low
  • AERT $0.51
  • INTS $1.50
  • 52 Week High
  • AERT $2.93
  • INTS $5.94
  • Technical
  • Relative Strength Index (RSI)
  • AERT 38.36
  • INTS 54.20
  • Support Level
  • AERT $0.56
  • INTS $2.00
  • Resistance Level
  • AERT $0.70
  • INTS $2.37
  • Average True Range (ATR)
  • AERT 0.11
  • INTS 0.31
  • MACD
  • AERT -0.01
  • INTS -0.00
  • Stochastic Oscillator
  • AERT 21.82
  • INTS 48.24

About AERT Aeries Technology Inc.

Aeries Technology Inc is a professional and management services partner offering a range of management consultancy services for private equity sponsors and their portfolio companies with engagement models that are designed to provide a mix of deep vertical specialty, functional expertise, and digital systems and solutions to scale, optimize and transform a client's business operations. It supports and drives its client's growth across the globe by providing a range of management consultancy services involving professional advisory services and operations management services to build and manage dedicated delivery centers in appropriate locations based on customer business needs.

About INTS Intensity Therapeutics Inc. Common stock

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with major unmet medical need.

Share on Social Networks: